Leadership Overview
Allucent has 5 executives leading key functions including strategy, information technology, marketing, clinical operations, and product development.
Focused on accelerating global drug development, Allucent delivers comprehensive solutions across diverse therapeutic areas to ensure novel treatments reach patients efficiently through expert-driven, individualized partnerships.
Focused on accelerating global drug development, Allucent delivers comprehensive solutions across diverse therapeutic areas to ensure novel treatments reach patients efficiently through expert-driven, individualized partnerships.
Leadership Roles at Allucent
Paula Stafford - Chief Executive Officer
Paula Stafford, the Chief Executive Officer at Allucent, directs the overarching corporate strategy and global vision for drug development services. Overseeing operations across 60 countries, the Chief Executive Officer ensures alignment between internal resources and the complex requirements of pharmaceutical clients. This leadership role involves driving long-term growth initiatives while maintaining the high standards of clinical excellence expected within the industry. By fostering a culture of individualized partnership, Paula Stafford directly impacts the ability of the organization to navigate regulatory hurdles and deliver life-saving treatments. Stafford maintains constant communication with the Board to refine the strategic roadmap, ensuring the company remains a leader in providing comprehensive research solutions. Through rigorous oversight of organizational performance, the Chief Executive Officer secures the stability and future expansion of the firm within the competitive global healthcare landscape.
Anita Nelsen - President, Clinical Trial Operations
Anita Nelsen, the President, Clinical Trial Operations at Allucent, manages the execution of complex clinical studies across more than 60 countries. Overseeing the daily performance of trial sites and research teams, the President, Clinical Trial Operations ensures strict adherence to regulatory standards and project timelines. This leadership role involves optimizing operational workflows to improve the efficiency of drug development programs. By providing hands-on guidance to regional managers, Anita Nelsen directly impacts the quality and reliability of clinical data. Nelsen works closely with the executive leadership to align operational capacity with client demands for novel treatment delivery. Through the implementation of standardized processes, the President, Clinical Trial Operations maintains high performance levels, ensuring that the company consistently meets the rigorous requirements of global pharmaceutical partners while supporting the successful advancement of therapeutic candidates.
Leslie Devos - President, Product Development Strategy
Leslie Devos, the President, Product Development Strategy at Allucent, designs the strategic frameworks that guide clients through the complexities of the drug development lifecycle. Overseeing the integration of scientific expertise and regulatory insights, the President, Product Development Strategy ensures that development plans are optimized for success. This leadership role involves identifying key milestones and potential risks to streamline the path from early-stage research to market delivery. By leveraging deep industry knowledge, Leslie Devos directly impacts the strategic direction of client projects. Devos collaborates with the broader leadership team to ensure that product development services remain at the forefront of innovation. Through the application of experience-driven insights, the President, Product Development Strategy enables the company to provide tailored solutions that address the specific needs of patients, ultimately accelerating the delivery of novel treatments to the global market.

Nathan Thompson - Chief Information Officer
Nathan Thompson, the Chief Information Officer at Allucent, architects the digital infrastructure necessary to support global clinical trial data management. Overseeing the integration of advanced technology systems, the Chief Information Officer ensures secure, compliant, and efficient data flow across all international operations. This leadership role involves implementing robust cybersecurity protocols to protect sensitive patient information while enabling seamless collaboration between research teams. By modernizing the technical stack, Nathan Thompson directly impacts the speed and accuracy of drug development processes. Thompson collaborates with other C-suite leaders to align digital capabilities with the broader mission of delivering novel treatments. Through the deployment of scalable cloud solutions, the Chief Information Officer optimizes internal workflows, ensuring that the company maintains a technological edge in the highly regulated pharmaceutical services market.

Steffany Cox - Chief Marketing Officer
Steffany Cox, the Chief Marketing Officer at Allucent, drives the global brand strategy and market positioning for comprehensive drug development solutions. Overseeing the communication of the company value proposition, the Chief Marketing Officer ensures that the unique partnership approach resonates with clients across diverse therapeutic areas. This leadership role involves executing multi-channel campaigns that highlight the 30 years of experience and the extensive international footprint. By analyzing market trends and client needs, Steffany Cox directly impacts the acquisition of new business and the strengthening of existing partnerships. Cox coordinates with the executive team to ensure that marketing initiatives support the overall growth objectives. Through strategic brand management, the Chief Marketing Officer elevates the visibility of the firm, positioning the organization as a premier partner for companies navigating the complexities of bringing new treatments to patients.

Explore Leadership Teams in Business Services
CenExel is a leading integrated, wholly owned, nationwide clinical research site network comprised of 18 Centers of Excellence in major metropolitan areas across the U. S. With 40+ years of experience, our Centers of Excellence deliver deep scientific expertise, premium data, operational efficiencies, and exceptional patient engagement to drive successful complex clinical trial outcomes. The world's most results-driven Pharma, Biotech, and Clinical Research Organizations trust our strategic approach and benefit from our collaboration and unified sites commitment to real world solutions.
Company Leadership RB
KM
KC
The Broad Institute of MIT & Harvard provides a comprehensive platform for cancer genomics research through its GDAC Firehose. It offers a variety of tools and resources, including data analysis, dashboards, and custom runs for various cancer types. The intended clients include researchers and clinicians in the field of cancer genomics who require access to standardized data and analytical tools. Their mission is to facilitate the responsible use of genomic data to advance cancer research and treatment.
Company Leadership JH

EL
Founded in 1967 and headquartered in Chicago, Illinois, Mérieux NutriSciences is a company that provides a range of tests and consultancy services to the food and nutrition industries.
Company Leadership NM
RV
MB
Pacific Northwest National Laboratory (PNNL) is a leading research institution focused on scientific discovery in chemistry, data analytics, and Earth sciences, as well as technological innovation in energy resilience and national security. The laboratory serves a diverse range of clients, including government agencies, industry partners, and academic institutions, providing advanced research and development services. PNNL's expertise spans various fields such as renewable energy, environmental management, and cybersecurity, aiming to create a safer and more sustainable world. With a commitment to collaboration and innovation, PNNL engages in global partnerships to address complex challenges in science and technology.
Company Leadership TB
AS

